|
Volumn 8, Issue 6, 2011, Pages 609-612
|
Hematopoietic stem cell transplantation and implications for cell therapy reimbursement
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
BREAST CANCER;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH SERVICE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
LUNG CANCER;
MEDICAID;
MEDICAL PRACTICE;
MEDICAL SOCIETY;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
REIMBURSEMENT;
UNITED STATES;
CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.);
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
TISSUE THERAPY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 79957801289
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2011.05.013 Document Type: Note |
Times cited : (12)
|
References (10)
|